Bryan C. Hanson is the Chief Executive Officer of Solventum Corp., a global healthcare company spun off from 3M in April 2024, specializing in medical technologies, healthcare consumables, and purification solutions. With more than 25 years of leadership experience in the medtech and healthcare industries, Hanson has a distinguished career marked by driving commercial growth, operational excellence, and strategic innovation. Prior to Solventum, he served as President and CEO of Convatec Group Plc from 2015 to 2023, where he transformed the company into a high-performing organization focused on advanced wound care, infusion care, and ostomy solutions. Under Hanson's leadership at Convatec, the company achieved consistent double-digit revenue growth, expanded its global footprint through key acquisitions such as Prism Medical and Innerspace Neuro, and delivered strong shareholder returns, including a successful relisting on the London Stock Exchange. Earlier roles included Chief Operating Officer at Covidien (now part of Medtronic), where he oversaw global commercial operations, as well as senior positions at UnitedHealth Group and Boston Scientific, building expertise in strategy, business development, and international expansion. At Solventum, Hanson is guiding the company through its independence, emphasizing innovation, portfolio optimization, and customer-focused solutions to address pressing healthcare needs. His vision positions Solventum for sustainable growth, leveraging its $8.5 billion portfolio to improve patient outcomes and advance medtech leadership worldwide.